antioxidants Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits

Full text

antioxidants
Review
Hesperidin and SARS-CoV-2: New Light on the
Healthy Function of Citrus Fruits
Paolo Bellavite 1, * and Alberto Donzelli 2
1Department of Medicine, Section of General Pathology, University of Verona Medical School,
Strada Le Grazie 8, 37134 Verona, Italy
2Medical Doctor, Scientific Committee of Fondazione Allineare Sanitàe Salute, 20122 Milano, Italy;
adonzelli@ats-milano.it
*Correspondence: paolo.bellavite@univr.it
Received: 25 July 2020; Accepted: 11 August 2020; Published: 13 August 2020


Abstract:
Among the many approaches to Coronavirus disease 2019 (COVID-19) prevention, the
possible role of nutrition has so far been rather underestimated. Foods are very rich in substances,
with a potential beneficial effect on health, and some of these could have an antiviral action or
be important in modulating the immune system and in defending cells from the oxidative stress
associated with infection. This short review draws the attention on some components of citrus fruits,
and especially of the orange (Citrus sinensis), well known for its vitamin and flavonoid content.
Among the flavonoids, hesperidin has recently attracted the attention of researchers, because it binds
to the key proteins of the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several
computational methods, independently applied by different researchers, showed that hesperidin
has a low binding energy, both with the coronavirus “spike” protein, and with the main protease
that transforms the early proteins of the virus (pp1a and ppa1b) into the complex responsible for
viral replication. The binding energy of hesperidin to these important components is lower than that
of lopinavir, ritonavir, and indinavir, suggesting that it could perform an effective antiviral action.
Furthermore, both hesperidin and ascorbic acid counteract the cell damaging effects of the oxygen
free radicals triggered by virus infection and inflammation. There is discussion about the preventive
efficacy of vitamin C, at the dose achievable by the diet, but recent reviews suggest that this substance
can be useful in the case of strong immune system burden caused by viral disease. Computational
methods and laboratory studies support the need to undertake apposite preclinical, epidemiological,
and experimental studies on the potential benefits of citrus fruit components for the prevention of
infectious diseases, including COVID-19.
Keywords:
citrus fruits; Citrus sinensis; hesperidin; virus and oxidative stress; COVID-19; vitamin C;
SARS-CoV-2; sweet orange
1. Introduction
Coronavirus disease 2019 (COVID-19), being a new and largely unknown disease, has provided
doctors with the need to investigate and try new approaches and interventions. In the early stages of
the pandemic, many attempts were prompted by urgency, but now, our knowledge is increasing and
consolidating. On the prevention front, various measures have been put in place, and recommendations
have been issued, although not all based on rigorous evidence. Many hopes have been placed on
vaccines, but their feasibility, efficacy and safety are still very uncertain. Although clinical trials are
underway to test several antivirals and other agents, an important question for the population is
whether there are any nutrients and food/nutrition patterns that can prevent viral infection or mitigate
its severity. Diet seems to be a neglected or at least underestimated aspect, although it is acknowledged
Antioxidants 2020,9, 742; doi:10.3390/antiox9080742 www.mdpi.com/journal/antioxidants

Antioxidants 2020,9, 742 2 of 18
that it often plays an important role in the prevention of various diseases, even those of an infectious
nature [1–6].
Among the benefits of the Mediterranean diet for the protection from many diseases, there is also
the high consumption of foods rich in bioactive substances such as polyphenols and vitamins, including
vitamins A, C, D, E. Food polyphenols constitute a large family of substances, with beneficial effects
in a large group of communicable and non-communicable diseases. These compounds support and
improve the body’s defenses against oxidative stress and in the prevention of cardiovascular diseases,
atherosclerosis and cancer. In addition, they show anti-inflammatory, antiviral and antimicrobial
activities. This article considers the nutraceutical properties of citrus fruits, with particular attention to
hesperidin and vitamin C as potential medicines against Severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), for their activities as antiviral, antioxidants, and modulators of inflammation.
To enlighten the possible effect of the citrus components on COVID-19, it is useful to start with a
brief description of the virus’s infectivity and its pathology. Figure 1presents the main steps of the
viral cycle and its consequences on the cell, with the sites where the modulating action of hesperidin
and vitamin C might take place, as discussed in the subsequent chapters.
Figure 1.
Cellular cycle of the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus
and the places of the inhibition of virus-induced cellular and systemic pathology by hesperidin and
vitamin C (indicated with “X”).
The internalization of SARS-CoV-2 is mediated by the binding of the spike glycoprotein of the
virus with its receptor (ACE2) on the cell membranes. ACE2 is expressed in several tissues, including
alveolar lung cells, gastrointestinal tissue, and even the brain [
7
–
10
]. The viral particle is internalized in
a vesicle, whose envelope is then removed, allowing the genomic RNA to be released into the cytoplasm.
The ORF1a and ORF1b RNAs are produced by the genomic RNA, and then translated into pp1a and
pp1ab proteins, respectively. The pp1a and ppa1b proteins are then broken down by a proteolytic
process operated by viral enzymes, resulting in a total of 16 non-structural proteins. Some non-structural
proteins form a replication/transcription complex (RNA-dependent RNA polymerase), which uses
genomic RNA (+) as a model. Eventually, subgenomic RNAs produced through transcription are
translated into structural proteins that will form new viral particles. For this purpose, structural

Antioxidants 2020,9, 742 3 of 18
proteins are incorporated into the membrane and the nucleocapsid N protein combines with the
positive-sense RNA, produced through the replication process, to become a nucleoprotein complex.
In the Golgi endoplasmic reticulum-apparatus, the various components merge into the complete viral
particle, which is finally excreted in the extracellular milieu.
The new copies of the virus spread into the environment and infect other cells and organs in the
body, in a chain expansion. When the viral load is high and the cell is invaded by many viral particles,
all its protein synthesis apparatus is dedicated to viral replication, up to the cell death. The last phase
can take place with the “apoptosis” mechanism (if death is slow and controlled) or following an
“energetic-metabolic chaos”, such as to cause the breakdown of the various cell membranes, including
lysosomes, and a total loss of structural integrity. Possibly, also autoimmune phenomena are involved
in the attack to the infected cell by T-lymphocytes and antibodies [
11
]. Eventually, both in the tissue
where many cells have died (first of all in the lung), and systemically (lymph, blood, immune system,
coagulation, kidney, liver), an inflammatory reaction develops, which can be clinically very serious,
especially in patients with co-morbidities. Excessive and “vicious” inflammation can be mediated by a
distorted activation of the cytokine network, by clotting disorders, even by a paradoxical excess of the
immune reaction (autoimmunity, cytotoxic lymphocytes).
Based on this concise description, substances with a possible beneficial effect in coronavirus
infection may act in various stages: (a) preventing the binding of the virus to the receptors or inhibiting
the function of the receptor itself, when it sets in motion the internalization process, (b) inhibiting viral
replication by blocking, for example, RNA polymerase, proteases or new particle assembly, (c) helping
the cell to resist viral attack, i.e., stopping the cytotoxicity process, (d) blocking the spread of the
virus in the body, (e) modulating the inflammation when, starting as an innate defensive mechanism,
it becomes offensive and cytotoxic.
The prototype of the substances that act on steps (a) and (d) are specific antibodies, produced
by active or passive immunization (plasma, purified IgG), even if, in the case of coronaviruses, this
mechanism finds a complication in the risk of enhancement of the viral entry into target cells by the
same antibodies (“antibody-dependent-enhancement”) [
12
] or autoimmune reactions [
11
]. Step (b) is
the target of most antiviral drugs. Since the cytotoxicity process (step (c)) involves oxygen-derived free
radicals in many cell damage mechanisms, this pathologic process could be slowed down by natural
antioxidants. Finally, the modulation of the inflammatory disorders (e) can be tackled with a wide
variety of steroidal and non-steroidal anti-inflammatory drugs, or with new biological agents, such as
receptor antagonists or anti-cytokine antibodies.
Citrus fruits (Rutaceae family) are rich sources of vitamin C, anthocyanins, and flavanones,
with hesperidin and naringin as the most abundant components, which have various properties,
including antioxidant and anti-inflammatory activity [
4
,
5
,
13
]. Fibers such as pectin, more present
in the solid part, help to regulate intestinal functions and hinder the absorption of LDL cholesterol.
These fruits may also have beneficial effects in the prevention and treatment of viral and bacterial
infections [
14
–
16
]. Without neglecting the best known vitamin C, here we will examine the evidence,
albeit very preliminary, of a possible beneficial effect in COVID-19 of citrus fruits and their main
flavonoid, hesperidin. Hesperidin is the naturally occurring form and is the glycosylated form of
hesperetin, often used for its detection in plasma.
2. Contents and Bioavailability
Citrus sinensis (sweet orange) contains 0.2 g of fats, 0.7 g of proteins, 9.9 g of carbohydrates (soluble
sugars), and provides 45 kcal of energy per 100 g; the fresh sweet orange juice contains traces of
fats, 0.5 g of proteins, 9.8 g total carbohydrates (soluble sugars) and provides 39 kcal of energy per
100 mL [
17
,
18
]. Other active ingredients include vitamin C, carotenoids, flavanones [
19
,
20
]. Flavanones
are a group of phenolic natural chemical compounds belonging to the class of flavonoids, based on
the structure of the carbon atom skeleton of the flavone progenitor. Typical examples are the bitter
and soluble compounds present in the peel of citrus fruits as glycosides. The most important orange

Antioxidants 2020,9, 742 4 of 18
flavone is hesperetin, which is found in the fruit in a glycosylated form as hesperidin. The latter is
present mainly in the peel and in the white part (albedo) of citrus fruits, and consumption of the
whole fruits may allow a greater intake than the juice [
21
]. In fact, in fresh orange juice, the content of
hesperidin is about 30 mg per 100 mL, and in commercial juice it can be a little higher [
22
], probably
because the industrial processing incorporates more peel.
There are no major differences between the different varieties of oranges and between orange,
clementine and tangerine (Table 1). Moreover, lemons contain an amount of hesperidin (in mg/100 mL)
comparable to that of oranges, but to drink a same volume of juice is more difficult. The flavonoid
content of the red orange [
23
] is mainly hesperidin (43.6 mg/100 mL), followed at a distance by narirutin
(4.8 mg/100 mL) and dimidine (2.4 mg/100 mL).
Table 1.
Hesperidin content (mg/100 mL of fresh juice) in different citrus fruits. Data are from the
reviews of Gattuso et al. [22] and, for red orange, of Grosso et al. [23]
Fruit Hesperidin Content (mg/100 mL Juice)
mg SD Min. Max.
Citrus sinensis (sweet orange) 28.6 11.9 3.5 55.2
Citrus sinensis (red orange) 43.6 17.9 18 66.5
Commercial sweet orange juice 37.5 19.2 4.45 76.3
Citrus reticulata (mandarin) 24.3 18.2 0.81 45.8
Citrus clementine (clementine) 39.9 29.4 5.21 86.1
Citrus limon (lemon) 20.5 12.4 3.84 41
Citrus aurantifolia (lime) 1.8 0.35 1.52 2.0
Citrus paradisi (grapefruit) 0.9 0.58 0.25 1.8
Commercial grapefruit juice 2.8 3.9 0.2 16.4
According to a recent review [
24
], the content of hesperidin in 100 mL of juice is: orange 20–60 mg,
tangerines 8–46 mg, lemon 4–41 mg, grapefruit 2–17 mg. This means that we can take about 100 mg of
hesperidin, just in a large glass of orange juice. Based on these data, it can be said that the choice of the
most suitable fruits for a better intake of hesperidin could be made between oranges, mandarins and
clementines, according to individual preferences, and costs.
Note that the higher levels of hesperidin (and of other flavonoids) are in citrus peel: flavedo
and albedo. The concentration in the albedo is at least one order of magnitude greater than that of
the juice [
24
]. Therefore, the greater intake could be obtained by preferring citrus fruits from organic
farming, of which you can also eat the peel.
Some tests have assessed the amount of hesperidin (or its metabolite hesperetin) in the blood
of people drinking orange juice. Healthy volunteers drank orange juice in one intake (8 mL/kg) and
blood and urine samples were collected between 0 and 24 h after administration [
25
]. The peak plasma
concentration of hesperetin was 2.2 ±1.6 micromol/L, with significant variations in different subjects.
Elimination half-life ranged from 1.3 to 2.2 h, indicating short-term kinetics. In another experiment [
26
],
after a night fast, five healthy volunteers drank 0.5 or 1 L of commercial orange juice, containing
444 mg/L of hesperidin, along with a polyphenol-free breakfast. The flavanone metabolites appeared
in the plasma 3 h after the ingestion of the juice, peaked between 5 and 7 h, then returned to the
baseline value at 24 h. The peak plasma concentration of hesperetin was 0.46
±
0.07 micromol/L and
1.28
±
0.13 micromol/L, after taking 0.5 and 1 L, respectively. The authors concluded that, in the case of
moderate or high consumption of orange juice, flavanones represent an important part of the pool of
total polyphenols in plasma.
However, it would not be correct to evaluate the bioavailability of phenols only with the dosage of
hesperetin. In fact, there is evidence that hesperidin and naringin are metabolized by intestinal bacteria,
mainly in the proximal colon, with the formation of their aglycones, hesperetin and naringenin and
various other small phenols [
27
]. Studies have also shown that citrus flavanones and their metabolites
are able to influence the composition and activity of the microbiota, and to exert beneficial effects

Antioxidants 2020,9, 742 5 of 18
on gastrointestinal function and health. Other bioavailability studies have calculated that, if the
phenolic catabolites derived from the colon are added to the glucuronide and sulphate metabolites,
the polyphenols derived from orange juice are much more abundant and available than previously
thought [28,29].
Human studies have long shown the safety and good tolerability of hesperidin up to very high
doses [
24
]. In animal studies, hesperidin showed a good safety profile [
30
], with a median lethal dose
(LD50) of 4837.5 mg/kg, and in chronic administration up top, 500 mg/kg of the flavanone did not
induce any abnormalities in body weight, clinical signs and symptoms and blood parameters.
3. Hesperidin and the Virus
The discovery that the molecule of hesperidin has a chemical-physical structure suitable for
binding to key proteins in the functioning of the SARS-CoV-2 virus has recently aroused scientific
interest. At least six searches yielded concordant results [
31
–
36
]. The researchers started from the
detailed knowledge of the virus protein structure, to ascertain which molecules, natural or artificial,
are capable of binding with a low binding energy (the lower the energy required, the stronger and
more specific the binding is). This technique, called “in silico”, is currently applied to predict drug
behavior and accelerate the detection rate, since it allows screening many drugs, reducing the need for
expensive laboratory work and limiting clinical trials to the best candidates.
Wu and collaborators [
31
] have tested 1066 natural substances with potential antiviral effect, plus
78 antiviral drugs already known in the literature, for their binding to SARS-CoV-2 proteins. Of all,
hesperidin was the most suitable to bind to the “spike”. By superimposing the ACE2—receptor binding
domain (RBD) complex on the hesperidin—RBD complex, a clear overlap of hesperidin with the ACE2
interface is observed, which suggests that hesperidin may disrupt the interaction of ACE2 with RBD.
A second theoretical site of low energy binding of hesperidin with SARS-CoV-2 is the main
protease that allows the processing of the first proteins transferred from the viral genome-pp1a and
pp1ab-into functional proteins in the host cell [
31
]. This enzyme is called “3Clpro” or “Mpro” by the
various authors, and is the target of many chemical antiviral drugs. This specific binding has also been
confirmed by other authors: in a screening of 1500 potential molecules capable of binding to 3CLpro,
hesperidin is the second most efficient for binding to chain A, with a free energy of
−
10.1 kcal mol
−1
[
32
].
Lopinavir (
−
8.0) and ritonavir (
−
7.9) are given as reference drugs, and they show less binding capacity.
The binding to chain B occurs with
−
8.3 kcal mol
−1
, while lopinavir (
−
6.8) and ritonavir (
−
6.9) have
lower binding capacity.
Another detailed molecular docking study of the interaction between hesperidin and Mpro
was recently published [
35
]. In a screening of 33 natural and already known antiviral molecules,
the authors found that the lower binding energy (indicating maximum affinity) is characteristic of
rutin (
−
9.55 kcal/mol), followed by ritonavir (
−
9.52 kcal/mol), emetine (
−
9.07 kcal/mol), hesperidin
(
−
9.02 kcal/mol), and indinavir (8.84 kcal/mol). Hesperidin binds with hydrogen bonds to various
amino acids, mainly THR24, THR25, THR45, HIS4, SER46, CYS145. Further evidence came from the
work by Joshi et al. [
36
], who identified hesperidin among several natural molecules that strongly
bind to SARS-CoV-2 main protease, and interestingly also to the viral receptor angiotensin-converting
enzyme 2 (ACE-2).
A research published by Indonesian authors and so far available in preprints has examined with
computational methods a wide range of active principles of the medicinal plants Curcuma sp., Citrus sp.
(orange), Caesalpinia sappan and Alpinia galanga, for their ability of “molecular docking” towards viral
proteins [
34
]. For the three major proteins involved in virus infection, hesperidin was the most efficient
binding molecule, with docking points of
−
13.51,
−
9.61 and
−
9.50 respectively to the SARS-CoV-2
protease, to the glycoprotein-RBD Spike and to the ACE2 receptor. Hesperidin performs a better
interaction with the SARS-CoV-2 protease than lopinavir, a reference drug used today in the clinical
trials for Covid-19. These authors have observed that, in addition to hesperidin, other orange flavonoids
less represented quantitatively, like tangeretin, naringenin and nobiletine, also have a low binding

Antioxidants 2020,9, 742 6 of 18
energy (comparable to the reference ligands, lopinavir and nafamostat) to the three essential proteins,
suggesting that these interactions could also contribute to the inhibitory effect against virus infection.
According to another “molecular docking” research study [
33
], out of 26 natural phenolic compounds
that are candidates for antiviral action, hesperidin was the one with the highest binding capacity to the
crystallized form of the main protease of SARS-CoV-2. The flavanone interacts with several amino acids
of the protein through hydrogen bonds, and the interaction of hesperidin is more effective than that
realized by the reference drug nelfinavir (with scores of −178.59 and −147.38 respectively).
There is an important precedent when the authors studied natural compounds capable of inhibiting
3CLpro of the SARS virus [
37
], using cell-based proteolytic cleavage assays. Out of seven phenolic
compounds tested, hemodyne and hesperetin inhibited proteolytic activity in a dose-dependent
manner, with IC50 of 366 micromol/L and 8.3 micromol/L respectively. Interestingly, this research
suggests that the inhibition of viral protease occurs at concentrations of hesperidin of the same order
of magnitude as those achievable in plasma, with a large oral supplement of orange juice. Since
coronavirus main protease structural backbone and active site conformation are conserved despite
sequence variations [
36
], it is conceivable that the inhibitory effect of hesperidin previously observed
in SARS virus can be exploited also in SARS-CoV-2.
4. Antioxidant Activity
An efficient oxidative metabolism at the mitochondrial level (without unwarranted formation of
free radicals) and the balance of oxidation reactions, due to the intervention of the enzymatic systems
and various scavenger molecules, are essential for the vitality of the cells of each tissue. Several viruses
break this balance and induce oxidative stress, which in turn facilitates specific phases of the life
cycle of SARS-CoV-2 [
38
], and eventually cell death (Figure 2). Hesperidin contributes significantly to
antioxidant defense systems as an effective agent against superoxide and hydroxyl radicals [
39
], and
its derivative hesperetin inhibits nitric oxide production by LPS-stimulated microglial cells [40].
Figure 2.
Schematic representation of the mechanisms of generation of oxygen free radicals in the
course of Coronavirus disease 2019 (COVID-19), and assumptions about the antioxidant (A.O.) action
sites, indicated with “X”.

Antioxidants 2020,9, 742 7 of 18
Systemic perturbations associated with the severity of COVID-19 disease include free heme
release and hyperferritinemia, a sign of dysregulation of iron metabolism, which in turn induces the
production of reactive oxygen species, such as superoxide anion (O
2−
), hydrogen peroxide (H
2
O
2
);
hydroxyl radical (
·
OH), and promotes the oxidative stress [
41
,
42
]. In this pathological process, the
dysfunction of mitochondrial oxidative metabolism also plays an important role, leading to platelet
damage and promoting the formation of thrombi [
43
]. Another experimental model of generation
of free radicals is represented by ischemia and reperfusion (I/R). This occurrence has been described
also in COVID-19 [
44
], or can aggravate the treatment with drugs such as chloroquine [
45
]: during
prolonged hypoxia of a tissue, the cells undergo structural damage, especially in the mitochondria and
the endoplasmic reticulum. In addition, the purine metabolism ends with the formation of abundant
quantities of xanthine. When the oxygen brought by the blood returns to the same tissue, these
biochemical mechanisms—i.e., the mitochondrial chain, the endoplasmic reticulum and xanthine
oxidase—generate a monovalent reduction of oxygen with the formation of superoxide and other chain
radicals. Studies on rodents undergoing repeated hepatic ischemia-reperfusion sessions suggest that
hesperidin is a potential therapeutic agent for liver I/R lesions [
39
]. Finally, an important source of free
radicals during infection are the enzyme NADPH oxidase of phagocytic cells (neutrophils, eosinophils,
macrophages) which, activated by the inflammatory process, produce large quantities of toxic oxygen
derivatives with a microbicidal function [
46
]. Under particular circumstances, when their production
is in excess or the scavenger systems are inefficient or saturated, reactive oxygen species may escape
from the cell that produces them and be released into the extracellular environment, becoming harmful
and amplifying the injury due to inflammation [47,48].
Many studies have highlighted the importance of intracellular redox status as a new target for
natural medicines, or synthetic drugs aimed at blocking both viral replication and virus-induced
inflammation [
38
]. It has been suggested that, during COVID-19, the early treatment with antioxidants,
such as N-acetylcysteine [
49
,
50
], melatonin [
51
,
52
], polyphenols [
53
–
55
], K, C, D, and E vitamins
supplementation [56].
In this context, hesperidin might show some utility, due also to its antioxidant properties. Although
no studies have been conducted so far directly aimed at proving hesperidin in COVID-19, the fact that
it also has a powerful antioxidant action suggests that it could also have a beneficial effect through a
protection mechanism against virus-induced cytotoxic damage.
Various
in vitro
and
in vivo
studies have shown that hesperidin’s antioxidant activity is not
limited to its free radical scavenger activity, but also increased cellular defenses against oxidative
stress and reduced inflammation makers via the ERK/Nrf2 signaling pathway [
57
]. Cisplatin-treated
HK-2cells undergo oxidative stress and apoptosis, which are attenuated by hesperetin, by reducing
ROS levels and activating the Nrf2 signaling pathway, which in turn regulates the antioxidant response
elements [
58
]. Paracetamol is a common antipyretic and analgesic drug, but its overdose can cause
acute liver failure, with a mechanism involving oxidative stress [
59
], that is mitigated by pre-treatment
with hesperetin in a dose-dependent manner [60].
Hesperidin could be particularly useful in elderly people who suffer from greater oxidative
stress. Although the reasons for a difference in severity of COVID-19 disease in subjects of different
ages are unclear, it has been suggested that a key factor is the high antioxidant capacity of children,
and the redox imbalance of elderly subjects with low antioxidant capacity [
61
,
62
], perhaps because the
intracellular redox environment alters the presentation of antigens [
63
] and the expression or function
of ACE2 [
64
,
65
]. The results of another study indicate the beneficial effects of citrus flavanones in the
old-aged rat liver, where naringenin and hesperidin prevented the age-linked decrease of catalase,
superoxide dismutase and glutathione reductase [
66
]. Hesperidin demonstrated antioxidant activity
in rats after an intensive training program, and attenuated the secretion of cytokines by stimulated
macrophages [
67
,
68
]. The administration of hesperetin has been shown to significantly reduce the
levels of myeloperoxidase, malondialdehyde (a marker of lipid peroxidation) and inflammation in
experimental models of colitis [
69
] and hepatic trauma [
70
]. In a model of rheumatic arthritis induced by

Antioxidants 2020,9, 742 8 of 18
Freund’s complete adjuvant, hesperidin successfully reversed the signs and symptoms, inflammatory
markers and lipid peroxidation [71].
An interesting study compared the antioxidant capacity of the plasma of human subjects after
the ingestion of 150 mL of different fruit juices [
72
]. A significant free radical elimination effect was
observed already after 30 min, and up to 90 min after the ingestion of apple, orange, grape, peach,
plum, kiwi, melon and watermelon juices, but not of pear juice. The grape juice showed a slightly
longer lasting effect (up to 120 min after ingestion). No study, however, has evaluated the anti-viral
effect of different fruits, but the data reported above in Sections 2and 3suggest that it is mainly
attributable to citrus fruits, due to their distinctive content of hesperidin.
5. Vitamin C
This article focuses more on hesperidin for its newly suggested anti-SARS-CoV-2 properties,
but the importance of vitamin C, perhaps the best-known component of citrus fruits, cannot be
overlooked. Vitamin C is the main antioxidant component of orange, and in normal nutrition it
contributes, according to various authors, from 15% to 30% of the total antioxidant power of plasma [
73
].
The level of ascorbic acid in commercial orange juices (100%) ranges from about 35 mg/100 mL to about
74 mg/100 mL [
73
]. The consumption of blood oranges contributes to a daily intake of 9.4 mg/d (up to
55 mg/d) of anthocyanins and 58.5 mg/d (up to 340 mg/d) of vitamin C, respectively [
74
]. Citrus fruit
samples (Sanguinello and Tarocco cultivars) showed vitamin C values higher than 54.9 mg/100 g of
edible portion [75].
In COVID-19, a complementary therapeutic effect of intravenous high doses of vitamin C has
been reported [
76
,
77
] and clinical trials are ongoing [
78
], but high doses of ascorbate may also be
detrimental [
79
]. The role of dietary interventions is much more difficult to assess and any suggestion
at present is just speculative or, at best, a working hypothesis [80].
There are conflicting data on the effect of vitamin C to prevent the common cold and other
respiratory diseases. Coronaviruses are among the viruses that cause the common cold, a disease that
has never had an effective cure or vaccine. Considering that SARS-CoV-2 is a coronavirus, and taking
into account the low cost and high safety of natural foods rich in vitamin C, it has been suggested that
it might be useful to increase the daily intake of these foods during the COVID-19 pandemic [
80
–
82
].
However, while many studies on the efficacy of vitamin C mega doses in preventing respiratory
diseases are inconclusive or negative, meta-analyses suggest a consistent and statistically significant
benefit of vitamin C for preventing the common cold and in people exposed to short periods of stress,
intense exercise or in a cold environment [83,84].
Vitamin C, in addition to participating in the synthesis of collagen in the connective tissue, has
a strong antioxidant effect, able to reduce the effects of free radicals, together with other vitamins,
enzymes and minerals (zinc, selenium). Vitamin C is believed to prevent the oxidation of LDL and
to protect human vascular smooth muscle cells from apoptosis [
23
] and boosts immune functions
CARR2017}. Studies on animals infected with the flu virus have shown that vitamin C stimulates
anti-viral immune responses and reduces the lungs’ inflammatory state [
85
,
86
]. We suggest that a
beneficial effect of low-medium doses of vitamin C in the first stages of COVID-19 infection could also
be due to the protection of cells from damage caused by the virus and/or by free radicals produced in
the course of dysregulated inflammatory and immunopathological reactions.
The beneficial effects of an adequate amount of citrus fruits or of the integration of diet with vegetal
extracts may result from the synergistic effects of their components [
87
], which provide protection
against virus replication and oxidative damage.
6. Other Useful Effects
Hesperidin has multiple antimicrobial, antioxidant, anti-tumor, antihypertensive and
immunostimulant medicinal properties [
14
,
57
,
88
–
97
]. Therefore, citrus fruits could have positive effects

Antioxidants 2020,9, 742 9 of 18
in the course of COVID-19 with additional mechanisms, besides the inhibition of virus replication and
antioxidant activity.
In the most advanced stages, this disease presents multiple and complex systemic features:
hypercoagulation, hyperactivation of the systemic inflammatory reactions, and a pathology that
involves the blood vessels of the lung and other organs. For example, it has been argued that the mixture
of hesperidin with diosmin co-administered with heparin protects against venous thromboembolism,
which is a serious lung complication of the COVID-19 disease [
98
]. A randomized, single-blind,
placebo-controlled, cross-over study in subjects with increased cardiovascular risk (aged 27 to 56
years) tested the administration of 500 mL of blood orange (dark red-colored Citrus sinensis) juice/day
(or 500 mL of placebo/day) for periods of 7 days [
99
]. Endothelial function, measured as flow-mediated
dilation, improved greatly and was normalized (5.7% compared to 7.9%; p<0.005), after 1 week
of consuming red orange juice. The concentrations of C-reactive protein, IL-6 and TNF-alpha also
decreased significantly (p<0.001).
Furthermore, this infection is known to affect elderly people with other cardiovascular and
respiratory systems ailments. Consequently, any lifestyle-related intervention, including dietary
interventions that increase hesperidin bioavailability [
95
] and help to maintain the health of the
cardiovascular and respiratory systems, may make the person infected with SARS-CoV-2 less susceptible
to its more severe complications. The risk of some chronic diseases like cerebrovascular disease and
asthma is lower at higher dietary hesperetin intake [
100
], and a number of papers report beneficial
effects in animal models of neurodegenerative disorders [
96
,
101
,
102
] and hyperthermia-induced febrile
seizures [
103
]. Gene expression analysis has shown that hesperidin modulates the expression of
genes involved in atherogenesis, inflammation, cell adhesion and cytoskeletal organization [
104
].
Physiologically relevant concentrations of flavanone reduce the adhesion of monocytes to endothelial
cells stimulated by TNF-alpha, influencing the expression of related genes, and offering a potential
explanation of its vasculoprotective effects. A daily dose of 292 mg of hesperidin, corresponding to
500 mL of orange juice, was sufficient to achieve the described effects.
A randomized controlled crossover study [
105
] of 24 healthy and overweight men (age 50–65 years)
investigated the effects of orange and hesperidin on the vascular system. During three periods of four
weeks, the volunteers consumed 500 mL of orange juice, 500 mL of control drink, plus hesperidin, or
500 mL of control drink plus placebo every day. After 4 weeks of consuming orange juice or control
drink plus hesperidin, the diastolic pressure had significantly decreased compared to control drink
plus placebo (p=0.02). Both orange juice and control drink plus hesperidin ingestion improved
postprandial microvascular endothelial reactivity compared to placebo (p<0.05), measured at the
peak of plasma concentration of hesperetin. The authors conclude that, in healthy middle-aged men in
moderate overweight, the regular consumption of orange juice reduces diastolic pressure and increases
endothelium-dependent microvascular reactivity. The study suggests that this beneficial effect is due
to hesperidin. Various
in vivo
experiments revealed the protective effects of hesperidin against the
inflammation produced by lipopolysaccharide (LPS) in liver and spleen [106].
Studies in mice showed protective effects of hesperetin in LPS-induced neuroinflammation,
neuronal oxidative stress and memory impairment [
107
]. Hesperetin significantly reduced the
expression of inflammatory cytokines in microglia, and attenuated the generation of reactive oxygen
species induced by LPS. In addition, hesperetin improved synaptic integrity, cognition and memory
processes. In a recent review, it was noted that the nutraceutical, antioxidant and anti-inflammatory
properties of hesperidin could be useful also in neurodegenerative diseases [
101
]. A dietary medical
history study determined the total dietary intake of 10,054 Finnish men and women in the previous
year [
100
]. Flavonoids intake in food was estimated and compared with the incidence of diseases
considered by different national public health registers. People with higher hesperetin intakes had
lower incidences of cerebrovascular disease (RR 0.80; CI 0.64–0.99; p=0.008) and bronchial asthma
(RR 0.64; CI 0.46–0.88; p=0.03).

Antioxidants 2020,9, 742 10 of 18
The effect of orange juice on inflammation and oxidative stress induced by a high-fat meal was
studied [
108
] in three groups of 10 normal and healthy subjects, invited to drink water, or 300 kcal of
glucose, or juice orange, in combination with a high-fat meal of 900 kcal. In blood samples obtained
before, and 1, 3 and 5 h after the consumption of the meal and of the different drinks, some indexes of
inflammation were determined. The high-fat meal increased the expression of NADPH oxidase, toll-like
receptors and metalloproteinase-9 in mononuclear cells and plasma. These changes were significantly
reduced by the intake of orange juice. Other authors [
72
,
109
] have also described antioxidant effects in
healthy volunteers after taking orange juice and whole fruits rich in vitamin C.
Since COVID-19 disease is a multi-organ disease and has more serious clinical consequences
in subjects suffering from co-morbidities and cardiovascular pathologies, it is conceivable that
its clinical course could benefit from the multiple valuable effects of hesperidin in systemic and
chronic-degenerative pathologies.
7. Discussion
The scientific literature on the healthy properties of fruit and vegetables [
5
,
18
,
29
,
110
–
114
] is vast
and beyond the scope of this article, which has focused on the remarkable and surprising interaction
between hesperidin, and the key proteins of the SARS-CoV-2 virus, seen by means of computational
simulations. Since these methods are now the “gold standard” for screening new drugs and their
targets, we can hypothesize the beneficial effects of hesperidin in COVID-19 as well, pending the
need of clinical evidence of therapeutic efficacy. The binding of hesperidin to the central part of the
spike and to the main protease is much stronger than that of conventional antivirals, and it can be
expected that this molecule may soon be tested in randomized trials of patients with COVID-19 or
subjects exposed to contagion, as is the case for quercetin, or for a mix of quercetin, green tea, cinnamon
and liquorice [
115
]. These new pharmacological properties of hesperidin are added to those of an
antioxidant agent, already known.
A systematic review with dose-response meta-analysis of prospective studies studying the
relationship between fruit, vegetables and cardiovascular diseases, total cancer and all-cause
mortality [
116
], found a non-linear relationship between citrus fruits intake and all-cause mortality,
with the nadir for an average consumption between 50 and 100 g/day, and with an apparent tendency
of the dose-response curve to lose any benefit around 250 g per day. This might happen because of
sweetened juices, as the consumption of sugary drinks/high-sugar beverages in the USA was associated
with an increase in mortality [
117
]. An average consumption of citrus fruit close to 100 g/day would
seem optimal, preferring whole fruits, which are associated with a maximum intake also of hesperidin,
in addition to dietary fiber and other nutrients, in comparison with juices or centrifuged drinks.
In general, it cannot be argued that citrus fruits are healthier than other fruits [
72
,
116
], but it is
certainly true for their hesperidin content, and therefore for their possible protective effect against
COVID-19. The recently accumulated evidence suggests that hesperidin supplementation may be
useful as prophylactic agent against SARS-CoV-2 infection and as complementary treatment during
COVID-disease, as recently suggested by others [
24
,
98
]. In support of this hypothesis, the latter work
cited the in silico study of Wu et al. [
31
], and proposed that the benefit of hesperidin may derive
both from the binding to the coronavirus spike and from its anti-inflammatory activity. As it appears
from our review, several other research groups [
32
–
36
] have been added to the work of Wu et al. [
31
],
showing low binding energy to other viral proteins besides to spike. In this work, we have also given
importance to further biological actions of citrus fruits, in protecting the cell from damage caused by
the virus and the oxidative stress. Moreover, from our point of view, it is important to consider, in
addition to the effect of the single molecule, also the set of benefits of citrus fruits and whole fruit
juice. In fact, orange, lemon and mandarin contain a significant amount of hesperidin that can be taken
through the diet, and contain also vitamin C, which has nutraceutical properties that could synergize
with the flavanone.

Antioxidants 2020,9, 742 11 of 18
Whether regular citrus consumption, or an increase in consumption, may be advisable among the
preventive dietary measures for COVID-19 is a matter of future investigations. A dose of citrus fruits
or vitamin C-based supplements, higher than that of a typical diet of the Italian population, does not
seem suitable for long-term prevention. However, in periods of intense stress (that may be considered
similar to the exposure to pathogenic microorganisms during the epidemic peak or during another
infectious disease), possible benefits from high doses of vitamin C are expected [
84
]. It was suggested
that the prevention of infection requires dietary intakes of vitamin C (i.e., 100–200 mg/day) [
118
], which
provide adequate plasma levels to optimize cell and tissue levels, while the treatment of established
infections may probably require significantly higher doses; high (grams) in vitamin to compensate for
the increased inflammatory response and metabolic demand [
119
]. If you rely on food, these doses
may be reached with a temporary large consumption of juices, taking care to crush well also the albedo,
which is the part richest in hesperidin.
Following the computational evidence of the interaction between hesperidin and key viral proteins,
it is likely that this component will become part of the candidate drugs for a preventative or therapeutic
effect. In order to support a similar effect of dietary doses, adequate epidemiological studies would be
needed to compare the incidence of COVID-19 in populations with different dietary intake of oranges
and other citrus fruits, in an analogy with studies showing statistically significant benefits of specific
diet components in infectious diseases [
1
,
120
] and in cancer of the digestive tract [
121
]. We reported on
the bioavailability of hesperidin (about 2 micromol/L in plasma after ingestion of 500 mL of juice [
25
])
and the cited article, showing that micromolar doses of hesperidin inhibit the main protease of the
SARS virus [
37
]; this suggests that an infection-blocking effect could be approached or achieved, even
with an increase in citrus fruits intake for a certain period, particularly when consumed with peel
and albedo, richer in hesperidin than juice [
24
]. Furthermore, it is conceivable that a high dose of
nutraceutical principles should be present during and after the intake in the oral cavity and in the
digestive tract, thus providing a local impediment to virus entry and replication in these anatomic
sites, which play a crucial role in the COVID-19 disease [9,122,123].
Finally, quarantine is likely to have also negative effects on lifestyle and, including those related
to stress, anxiety, reduced physical activity and nutrition, with a consequent low intake of antioxidants
and vitamins. It has been suggested that, during quarantine, strategies to encourage adherence to an
adequate diet rich in fruits and vegetables should be implemented [124].
8. Conclusions
In conclusion, what we have reported here elucidates the multiple biological actions of hesperidin
and vitamin C, two major components of citrus fruits which appear to be effective candidates to
counteract the cell infection by SARS-CoV-2, and to modulate the systemic immunopathological phases
of the disease. Further preclinical, epidemiological and clinical studies are needed to corroborate the
hypothesis that an adequate intake of citrus fruits or their extracts could effectively contribute to the
strategies for the prevention of COVID-19.
Author Contributions:
Each author has made substantial contributions to the conception and design of the work.
Original draft preparation and literature investigation, P.B.; Review and supervision, A.D. All authors have read
and agreed to the published version of the manuscript.
Funding:
This research received no external funding. Article processing charges were supported by Fondazione
Allineare Sanitàe Salute, Milano, Italy.
Acknowledgments: We thank Donatella Sghedoni for her English revision of the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.

Antioxidants 2020,9, 742 12 of 18
References
1.
Aune, D.; Keum, N.; Giovannucci, E.; Fadnes, L.T.; Boffetta, P.; Greenwood, D.C.; Tonstad, S.; Vatten, L.J.;
Riboli, E.; Norat, T. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and
cause-specific mortality: A systematic review and dose-response meta-analysis of prospective studies.
BMC Med. 2016,14, 207. [CrossRef]
2.
Etemadi, A.; Sinha, R.; Ward, M.H.; Graubard, B.I.; Inoue-Choi, M.; Dawsey, S.M.; Abnet, C.C. Mortality
from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP Diet and
Health Study: Population based cohort study. BMJ 2017,357, j1957. [CrossRef]
3.
Aune, D.; Keum, N.; Giovannucci, E.; Fadnes, L.T.; Boffetta, P.; Greenwood, D.C.; Tonstad, S.; Vatten, L.J.;
Riboli, E.; Norat, T. Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular
disease, total cancer, and all-cause mortality: A systematic review and dose-response meta-analysis of
prospective studies. Am. J. Clin. Nutr. 2018,108, 1069–1091. [CrossRef]
4.
Wallace, T.C.; Bailey, R.L.; Blumberg, J.B.; Burton-Freeman, B.; Chen, C.-Y.O.; Crowe-White, K.M.;
Drewnowski, A.; Hooshmand, S.; Johnson, E.; Lewis, R.; et al. Fruits, vegetables, and health: A comprehensive
narrative, umbrella review of the science and recommendations for enhanced public policy to improve
intake. Crit. Rev. Food Sci. Nutr. 2019,60, 2174–2211. [CrossRef]
5.
Barreca, D.; Mandalari, G.; Calderaro, A.; Smeriglio, A.; Trombetta, D.; Felice, M.R.; Gattuso, G. Citrus
Flavones: An Update on Sources, Biological Functions, and Health Promoting Properties. Plants
2020
,9, 288.
[CrossRef]
6. Calder, P.C.; Carr, A.C.; Gombart, A.F.; Eggersdorfer, M. Optimal Nutritional Status for a Well-Functioning
Immune System Is an Important Factor to Protect against Viral Infections. Nutrients
2020
,12, 1181. [CrossRef]
7.
Patel, V.B.; Parajuli, N.; Oudit, G.Y. Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular
complications. Clin. Sci. 2013,126, 471–482. [CrossRef]
8.
Gupta, A.; Madhavan, M.V.; Sehgal, K.; Nair, N.; Mahajan, S.; Sehrawat, T.S.; Bikdeli, B.; Ahluwalia, N.;
Ausiello, J.C.; Wan, E.Y.; et al. Extrapulmonary manifestations of COVID-19. Nat. Med.
2020
,26, 1017–1032.
[CrossRef]
9.
Xu, H.; Zhong, L.; Deng, J.; Peng, J.; Dan, H.; Zeng, X.; Li, T.; Chen, Q. High expression of ACE2 receptor of
2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020,12, 1–5. [CrossRef]
10.
Nuzzo, D.; Picone, P. Potential neurological effects of severe COVID-19 infection. Neurosci. Res.
2020
.
[CrossRef]
11.
Lyons-Weiler, J. Pathogenic Priming Likely Contributes to Serious and Critical Illness and Mortality in
COVID-19 via Autoimmunity. J. Transl. Autoimmun. 2020,9, 100051. [CrossRef]
12.
Wan, Y.; Shang, J.; Sun, S.; Tai, W.; Chen, J.; Geng, Q.; He, L.; Chen, Y.; Wu, J.; Shi, Z.; et al. Molecular
Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. J. Virol. 2019,94. [CrossRef]
13.
Zhu, C.; Zhou, X.; Long, C.; Du, Y.; Li, J.; Yue, J.; Pan, S. Variations of Flavonoid Composition and
Antioxidant Properties among Different Cultivars, Fruit Tissues and Developmental Stages of Citrus Fruits.
Chem. Biodivers. 2020,17. [CrossRef]
14.
Iranshahi, M.; Rezaee, R.; Parhiz, H.; Roohbakhsh, A.; Soltani, F. Protective effects of flavonoids against
microbes and toxins: The cases of hesperidin and hesperetin. Life Sci. 2015,137, 125–132. [CrossRef]
15.
Goncalves, D.R.; Lima, C.; Ferreira, P.; Da Costa, P.I.; Costa, A.; Figueiredo, W.; Cesar, T.B. Orange juice as
dietary source of antioxidants for patients with hepatitis C under antiviral therapy. Food Nutr. Res.
2017
,61,
1296675. [CrossRef]
16.
Piva, H.M.R.; S
á
, J.M.; Miranda, A.S.; Tasic, L.; Fossey, M.A.; Souza, F.P.; Caruso, I. Insights into Interactions
of Flavanones with Target Human Respiratory Syncytial Virus M2-1 Protein from STD-NMR, Fluorescence
Spectroscopy, and Computational Simulations. Int. J. Mol. Sci. 2020,21, 2241. [CrossRef]
17.
Sanchez-Moreno, C.; Cano, M.P.; De Ancos, B.; Plaza, L.; Olmedilla-Alonso, B.; Granado, F.; Mart
í
n, A. Effect
of orange juice intake on vitamin C concentrations and biomarkers of antioxidant status in humans. Am. J.
Clin. Nutr. 2003,78, 454–460. [CrossRef]
18.
Rampersaud, G.C.; Valim, M.F. 100% citrus juice: Nutritional contribution, dietary benefits, and association
with anthropometric measures. Crit. Rev. Food Sci. Nutr. 2015,57, 129–140. [CrossRef]
19.
Singh, B.; Singh, J.P.; Kaur, A.; Singh, N. Phenolic composition, antioxidant potential and health benefits of
citrus peel. Food Res. Int. 2020,132, 109114. [CrossRef]

Antioxidants 2020,9, 742 13 of 18
20.
Najmanov
á
, I.; Vopršalov
á
, M.; Saso, L.; Mladˇenka, P. The pharmacokinetics of flavanones. Crit. Rev. Food
Sci. Nutr. 2019, 1–17. [CrossRef]
21.
Nogata, Y.; Sakamoto, K.; Shiratsuchi, H.; Ishii, T.; Yano, M.; Ohta, H. Flavonoid Composition of Fruit Tissues
of Citrus Species. Biosci. Biotechnol. Biochem. 2006,70, 178–192. [CrossRef]
22.
Gattuso, G.; Barreca, D.; Gargiulli, C.; Leuzzi, U.; Caristi, C. Flavonoid Composition of Citrus Juices. Molecules
2007,12, 1641–1673. [CrossRef]
23.
Grosso, G.; Galvano, F.; Mistretta, A.; Marventano, S.; Nolfo, F.; Calabrese, G.; Buscemi, S.; Drago, F.;
Veronesi, U.; Scuderi, A. Red Orange: Experimental Models and Epidemiological Evidence of Its Benefits on
Human Health. Oxidative Med. Cell. Longev. 2013,2013, 1–11. [CrossRef]
24.
Meneguzzo, F.; Ciriminna, R.; Zabini, F.; Pagliaro, M. Review of Evidence Available on Hesperidin-Rich
Products as Potential Tools against COVID-19 and Hydrodynamic Cavitation-Based Extraction as a Method
of Increasing Their Production. Processes 2020,8, 549. [CrossRef]
25.
Erlund, I.; Meririnne, E.; Alfthan, G.; Aro, A. Plasma kinetics and urinary excretion of the flavanones
naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J. Nutr.
2001
,131,
235–241. [CrossRef]
26.
Manach, C.; Morand, C.; Gil-Izquierdo, A.; Bouteloup-Demange, C.; R
é
m
é
sy, C. Bioavailability in humans of
the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr.
2003,57, 235–242. [CrossRef]
27.
Stevens, Y.; Van Rymenant, E.; Grootaert, C.; Van Camp, J.; Possemiers, S.; Masclee, A.A.M.; Jonkers, D.M.A.E.
The Intestinal Fate of Citrus Flavanones and Their Effects on Gastrointestinal Health. Nutrients
2019
,11,
1464. [CrossRef]
28.
Pereira-Caro, G.; Borges, G.; Ky, I.; Ribas, A.; Calani, L.; Del Rio, D.; Clifford, M.N.; Roberts, S.A.; Crozier, A.
In vitro
colonic catabolism of orange juice (poly)phenols. Mol. Nutr. Food Res.
2015
,59, 465–475. [CrossRef]
29.
Pereira-Caro, G.; Borges, G.; Van Der Hooft, J.J.J.; Clifford, M.N.; Del Rio, D.; Lean, M.E.; Roberts, S.A.;
Kellerhals, M.B.; Crozier, A. Orange juice (poly)phenols are highly bioavailable in humans. Am. J. Clin. Nutr.
2014,100, 1378–1384. [CrossRef]
30.
Li, Y.; Kandhare, A.D.; Mukherjee, A.A.; Bodhankar, S. Acute and sub-chronic oral toxicity studies of
hesperidin isolated from orange peel extract in Sprague Dawley rats. Regul. Toxicol. Pharmacol.
2019
,105,
77–85. [CrossRef]
31.
Wu, C.; Liu, Y.; Yang, Y.; Zhang, P.; Zhong, W.; Wang, Y.; Wang, Q.; Xu, Y.; Li, M.; Li, X.; et al. Analysis of
therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm.
Sin. B 2020,10, 766–788. [CrossRef]
32.
Chen, Y.W.; Yiu, C.B.; Wong, K.Y. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
(pro)) structure: Virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates.
F1000Research 2020,9, 129. [CrossRef]
33.
Adem, S.; Eyupoglu, V.; Sarfraz, I.; Rasul, A.; Ali, M. Identification of Potent COVID-19 Main Protease (Mpro)
Inhibitors from Natural Polyphenols: An in Silico Strategy Unveils a Hope against CORONA. Preprints
2020, 2020030333. [CrossRef]
34.
Utomo, R.Y.; Ikawati, M.; Meiyanto, E. Revealing the Potency of Citrus and Galangal Constituents to Halt
SARS-CoV-2 Infection. Preprints 2020,2020, 12. [CrossRef]
35.
Das, S.; Sarmah, S.; Lyndem, S.; Roy, A.S. An investigation into the identification of potential inhibitors of
SARS-CoV-2 main protease using molecular docking study. J. Biomol. Struct. Dyn. 2020, 1–11. [CrossRef]
36.
Joshi, R.S.; Jagdale, S.S.; Bansode, S.B.; Shankar, S.S.; Tellis, M.B.; Pandya, V.K.; Chugh, A.; Giri, A.P.;
Kulkarni, M.J. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2
structurally conserved main protease. J. Biomol. Struct. Dyn. 2020, 1–16. [CrossRef]
37.
Lin, C.-W.; Tsai, F.-J.; Tsai, C.-H.; Lai, C.-C.; Wan, L.; Ho, T.-Y.; Hsieh, C.-C.; Chao, P.-D.L. Anti-SARS
coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds.
Antivir. Res. 2005,68, 36–42. [CrossRef]
38. Wu, J. Tackle the free radicals damage in COVID-19. Nitric Oxide 2020,102, 39–41. [CrossRef]
39.
Park, H.-K.; Kang, S.W.; Park, M.-S. Hesperidin Ameliorates Hepatic Ischemia-Reperfusion Injury in
Sprague-Dawley Rats. Transplant. Proc. 2019,51, 2828–2832. [CrossRef]

Antioxidants 2020,9, 742 14 of 18
40.
Jo, S.H.; Kim, M.E.; Cho, J.H.; Lee, Y.; Lee, J.; Park, Y.-D.; Lee, J.S. Hesperetin inhibits neuroinflammation
on microglia by suppressing inflammatory cytokines and MAPK pathways. Arch. Pharmacal Res.
2019
,42,
695–703. [CrossRef]
41.
Cavezzi, A.; Troiani, E.; Corrao, S. COVID-19: Hemoglobin, iron, and hypoxia beyond inflammation.
A narrative review. Clin. Pract. 2020,10, 1271. [CrossRef]
42.
Wagener, F.A.D.T.G.; Pickkers, P.; Peterson, S.J.; Immenschuh, S.; Abraham, N.G. Targeting the Heme-Heme
Oxygenase System to Prevent Severe Complications Following COVID-19 Infections. Antioxidants
2020
,
9, 540. [CrossRef]
43.
Saleh, J.; Peyssonnaux, C.; Singh, K.K.; Edeas, M. Mitochondria and Microbiota dysfunction in COVID-19
pathogenesis. Mitochondrion 2020. [CrossRef]
44. Tian, D.; Ye, Q. Hepatic complications of COVID-19 and its treatment. J. Med. Virol. 2020. [CrossRef]
45.
Mubagwa, K. Cardiac effects and toxicity of chloroquine: A short update. Int. J. Antimicrob. Agents
2020
,
56, 106057. [CrossRef]
46.
Bellavite, P. The superoxide-forming enzymatic system of phagocytes. Free Radic. Biol. Med.
1988
,4, 225–261.
[CrossRef]
47.
Manea, S.-A. NADPH oxidase-derived reactive oxygen species: Involvement in vascular physiology and
pathology. Cell Tissue Res. 2010,342, 325–339. [CrossRef]
48.
Puertollano, M.A.; Puertollano, E.; Alvarez de Cienfuegos, G.; De Pablo, M.A. Dietary antioxidants: Immunity
and host defense. Curr. Top. Med. Chem. 2011,11, 1752–1766. [CrossRef]
49.
Poe, F.L.; Corn, J. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2. Med. Hypotheses
2020
,
143, 109862. [CrossRef]
50.
Nasi, A.; McArdle, S.; Gaudernack, G.; Westman, G.; Melief, C.; Rockberg, J.; Arens, R.; Kouretas, D.; Sjölin, J.;
Mangsbo, S. Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2
in an ageing population, consider N-acetylcysteine as early therapeutic intervention. Toxicol. Rep.
2020
,7,
768–771. [CrossRef]
51.
El-Missiry, M.A.; El-Missiry, Z.M.; Othman, A.I. Melatonin is a potential adjuvant to improve clinical
outcomes in individuals with obesity and diabetes with coexistence of Covid-19. Eur. J. Pharmacol.
2020
,
882, 173329. [CrossRef]
52.
Anderson, G.; Reiter, R.J. Melatonin: Roles in influenza, Covid-19, and other viral infections. Rev. Med. Virol.
2020,30. [CrossRef]
53.
Iddir, M.; Brito, A.; Dingeo, G.; Fernandez Del Campo, S.S.; Samouda, H.; La Frano, M.R.; Bohn, T.
Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and
Nutrition: Considerations during the COVID-19 Crisis. Nutrients 2020,12, 1562. [CrossRef]
54.
Filardo, S.; Di Pietro, M.; Mastromarino, P.; Sessa, R. Therapeutic potential of resveratrol against emerging
respiratory viral infections. Pharmacol. Ther. 2020,214, 107613. [CrossRef]
55.
Marinella, M.A. Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.
Int. J. Clin. Pract. 2020,15, e13535. [CrossRef]
56.
Beigmohammadi, M.T.; Bitarafan, S.; Hoseindokht, A.; Abdollahi, A.; Amoozadeh, L.; Abadi, M.M.A.;
Foroumandi, M. Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate
in ICU patients with coronavirus-19: A structured summary of a study protocol for a randomized controlled
trial. Trials 2020,21, 1–4. [CrossRef]
57.
Roohbakhsh, A.; Parhiz, H.; Soltani, F.; Rezaee, R.; Iranshahi, M. Molecular mechanisms behind the biological
effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci.
2015
,
124, 64–74. [CrossRef]
58.
Chen, X.; Wei, W.; Li, Y.; Huang, J.; Ci, X. Hesperetin relieves cisplatin-induced acute kidney injury by
mitigating oxidative stress, inflammation and apoptosis. Chem. Interact. 2019,308, 269–278. [CrossRef]
59.
Park, B.K.; Dear, J.W.; Antoine, D.J. Paracetamol (acetaminophen) poisoning. BMJ Clin. Evid.
2015
,10, 2101.
60.
Wan, J.; Kuang, G.; Zhang, L.; Jiang, R.; Chen, Y.; He, Z.; Ye, D. Hesperetin attenuated acetaminophen-induced
hepatotoxicity by inhibiting hepatocyte necrosis and apoptosis, oxidative stress and inflammatory response
via upregulation of heme oxygenase-1 expression. Int. Immunopharmacol. 2020,83, 106435. [CrossRef]
61.
Keles, E.S. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked
with host reactive oxidative stress and antioxidant capabilities. New Microbes New Infect.
2020
,36, 100723.
[CrossRef] [PubMed]

Antioxidants 2020,9, 742 15 of 18
62.
Delgado-Roche, L.; Mesta, F. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome
Coronavirus (SARS-CoV) Infection. Arch. Med. Res. 2020,51, 384–387. [CrossRef] [PubMed]
63.
Trujillo, J.A.; Croft, N.P.; Dudek, N.L.; Channappanavar, R.; Theodossis, A.; Webb, A.I.; Dunstone, M.A.;
Illing, P.T.; Butler, N.S.; Fett, C.; et al. The Cellular Redox Environment Alters Antigen Presentation.
J. Biol. Chem. 2014,289, 27979–27991. [CrossRef] [PubMed]
64.
Hati, S.; Bhattacharyya, S. Impact of Thiol–Disulfide Balance on the Binding of Covid-19 Spike Protein with
Angiotensin-Converting Enzyme 2 Receptor. ACS Omega 2020,5, 16292–16298. [CrossRef] [PubMed]
65.
Dalan, R.; Bornstein, S.R.; El-Armouche, A.; Rodionov, R.N.; Markov, A.; Wielockx, B.; Boehm, B.O. The ACE-2
in COVID-19: Foe or friend? Horm. Metab. Res. 2020,52, 257. [CrossRef]
66.
Miler, M.; Živanovi´c, J.; Ajdžanovi´c, V.; Orešˇcanin-Duši´c, Z.; Milenkovi´c, D.; Koni´c-Risti´c, A.; Blagojevic, D.;
Miloševi´c, V.; Šoši´c-Jurjevi´c, B. Citrus flavanones naringenin and hesperetin improve antioxidant status and
membrane lipid compositions in the liver of old-aged Wistar rats. Exp. Gerontol.
2016
,84, 49–60. [CrossRef]
67.
Ruiz-Iglesias, P.; Estruel-Amades, S.; Camps-Bossacoma, M.; Massot-Cladera, M.; Franch,
À
.; P
é
rez-Cano, F.J.;
Castell, M. Influence of Hesperidin on Systemic Immunity of Rats Following an Intensive Training and
Exhausting Exercise. Nutrients 2020,12, 1291. [CrossRef]
68.
Estruel-Amades, S.; Massot-Cladera, M.; Garcia-Cerd
à
, P.; P
é
rez-Cano, F.J.; Franch,
À
.; Castell, M.;
Camps-Bossacoma, M. Protective Effect of Hesperidin on the Oxidative Stress Induced by an Exhausting
Exercise in Intensively Trained Rats. Nutrients 2019,11, 783. [CrossRef]
69.
Polat, F.R.; Karaboga, I.; Polat, M.S.; Erboga, Z.; Yilmaz, A.; Güzel, S. Effect of hesperetin on inflammatory
and oxidative status in trinitrobenzene sulfonic acid-induced experimental colitis model. Cell. Mol. Biol.
2018,64, 58–65. [CrossRef]
70.
Duran, Y.; Karabo ˘ga, I. Effect of hesperetin on systemic inflammation and hepatic injury after blunt chest
trauma in rats. Biotech. Histochem. 2019,95, 297–304. [CrossRef]
71.
Ahmed, O.M.; Fahim, H.; Mahmoud, A.M.; Ahmed, E.A.E. Bee Venom and Hesperidin Effectively Mitigate
Complete Freund’s Adjuvant-Induced Arthritis Via Immunomodulation and Enhancement of Antioxidant
Defense System. Arch. Rheumatol. 2018,33, 198–212. [CrossRef] [PubMed]
72.
Ko, S.-H.; Choi, S.-W.; Ye, S.-K.; Cho, B.-L.; Kim, H.-S.; Chung, M.-H. Comparison of the Antioxidant
Activities of Nine Different Fruits in Human Plasma. J. Med. Food 2005,8, 41–46. [CrossRef] [PubMed]
73.
Licciardello, F.; Arena, E.; Rizzo, V.; Fallico, B. Contribution of Blood Orange-Based Beverages to Bioactive
Compounds Intake. Front. Chem. 2018,6. [CrossRef] [PubMed]
74.
Fallico, B.; Ballistreri, G.; Arena, E.; Brighina, S.; Rapisarda, P. Bioactive compounds in blood oranges (Citrus
sinensis (L.) Osbeck): Level and intake. Food Chem. 2017,215, 67–75. [CrossRef] [PubMed]
75.
Cebadera-Miranda, L.; Dom
í
nguez, L.; Dias, M.I.; Barros, L.; Ferreira, I.C.; Igual, M.; Mart
í
nez-Navarrete, N.;
Fern
á
ndez-Ruiz, V.; Morales, P.; Hurtado, M.C. Sanguinello and Tarocco (Citrus sinensis [L.] Osbeck): Bioactive
compounds and colour appearance of blood oranges. Food Chem. 2019,270, 395–402. [CrossRef] [PubMed]
76.
Hern
á
ndez, A.; Papadakos, P.; Torres, A.; Gonz
á
lez, D.; Vives, M.; Ferrando, C.; Baeza, J. Two known
therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev. Española
Anestesiol. Reanimación2020,67, 245–252. [CrossRef]
77.
Cheng, R.Z. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019
(COVID-19)? Med. Drug Discov. 2020,5, 100028. [CrossRef]
78.
Liu, F.; Zhu, Y.; Zhang, J.; Li, Y.; Peng, Z. Intravenous high-dose vitamin C for the treatment of severe
COVID-19: Study protocol for a multicentre randomised controlled trial. BMJ Open
2020
,10, e039519.
[CrossRef]
79.
Lehene, M.; Fischer-Fodor, E.; Scurtu, F.; H
ă
dade, N.D.; Gal, E.; Mot, A.C.; Matei, A.; Silaghi-Dumitrescu, R.
Excess Ascorbate is a Chemical Stress Agent against Proteins and Cells. Pharmaceuticals
2020
,13, 107.
[CrossRef]
80.
Messina, G.; Polito, R.; Monda, V.; Cipolloni, L.; Di Nunno, N.; Di Mizio, G.; Murabito, P.; Carotenuto, M.;
Messina, A.; Pisanelli, D.; et al. Functional Role of Dietary Intervention to Improve the Outcome of COVID-19:
A Hypothesis of Work. Int. J. Mol. Sci. 2020,21, 3104. [CrossRef]
81.
Kalantar-Zadeh, K.; Ward, S.A.; Kalantar-Zadeh, K.; El-Omar, E.M. Considering the effects of microbiome and
diet on SARS-CoV-2 infection: Nanotechnology roles. ACS Nano
2020
,14, 5179–5182. [CrossRef] [PubMed]
82.
Kalantar-Zadeh, K.; Moore, L.W. Impact of Nutrition and Diet on COVID-19 Infection and Implications for
Kidney Health and Kidney Disease Management. J. Ren. Nutr. 2020,30, 179–181. [CrossRef] [PubMed]

Antioxidants 2020,9, 742 16 of 18
83.
Douglas, R.M.; Hemila, H.; Chalker, E.; Treacy, B. Vitamin C for preventing and treating the common cold.
Cochrane Database Syst. Rev. 2007,18, CD000980.
84.
Hemila, H.; Chalker, E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst. Rev.
2013,31, CD000980. [CrossRef] [PubMed]
85.
Kim, Y.; Kim, H.; Bae, S.; Choi, J.; Lim, S.Y.; Lee, N.; Lee, W.J. Vitamin C is an essential factor on the anti-viral
immune responses through the production of interferon-alpha/beta at the initial stage of influenza A virus
(H3N2) infection. Immune Netw. 2013,13, 70–74. [CrossRef]
86.
Kim, H.; Jang, M.; Kim, Y.; Choi, J.; Jeon, J.; Kim, J.; Hwang, Y.-I.; Kang, J.S.; Lee, W.J. Red ginseng and
vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1
infection. J. Pharm. Pharmacol. 2016,68, 406–420. [CrossRef]
87.
De Kok, T.M.; Van Breda, S.G.; Manson, M.M. Mechanisms of combined action of different chemopreventive
dietary compounds: A review. Eur. J. Nutr. 2008,47 (Suppl. 20), 51–59. [CrossRef]
88.
Garg, A.; Garg, S.; Zaneveld, L.J.D.; Singla, A.K. Chemistry and pharmacology of the Citrus bioflavonoid
hesperidin. Phytother. Res. 2001,15, 655–669. [CrossRef]
89.
Ross, J.A.; Kasum, C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu. Rev. Nutr.
2002,22, 19–34. [CrossRef]
90.
Coelho, R.C.L.A.; Hermsdorff, H.H.M.; Bressan, J. Anti-inflammatory Properties of Orange Juice: Possible
Favorable Molecular and Metabolic Effects. Plant Foods Hum. Nutr. 2013,68, 1–10. [CrossRef]
91.
Roohbakhsh, A.; Parhiz, H.; Soltani, F.; Rezaee, R.; Iranshahi, M. Neuropharmacological properties and
pharmacokinetics of the citrus flavonoids hesperidin and hesperetin—A mini-review. Life Sci.
2014
,113, 1–6.
[CrossRef] [PubMed]
92.
Parhiz, H.; Roohbakhsh, A.; Soltani, F.; Rezaee, R.; Iranshahi, M. Antioxidant and Anti-Inflammatory
Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular
Mechanisms and Experimental Models. Phytother. Res. 2014,29, 323–331. [CrossRef] [PubMed]
93.
Chanet, A.; Milenkovic, A.; Manach, C.; Mazur, A.; Morand, C. Citrus Flavanones: What Is Their Role in
Cardiovascular Protection? J. Agric. Food Chem. 2012,60, 8809–8822. [CrossRef]
94.
Tejada, S.; Pinya, S.; Martorell, M.; Cap
ó
, X.; Tur, J.A.; Pons, A.; Sureda, A. Potential Anti-inflammatory
Effects of Hesperidin from the Genus Citrus. Curr. Med. Chem. 2019,25, 4929–4945. [CrossRef] [PubMed]
95.
Mas-Capdevila, A.; Teichenne, J.; Domenech-Coca, C.; Caimari, A.; Del Bas, J.M.; Escot
é
, X.; Crescenti, A.
Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin
Bioavailability. Nutrients 2020,12, 1488. [CrossRef]
96.
Khan, A.; Khan, M.S.; Hahm, J.R.; Kim, M.O. Antioxidant and Anti-Inflammatory Effects of Citrus Flavonoid
Hesperetin: Special Focus on Neurological Disorders. Antioxidants 2020,9, 609. [CrossRef]
97.
Jiang, S.; Wang, S.; Zhang, L.; Tian, L.; Li, L.; Liu, Z.; Dong, Q.; Lv, X.; Mu, H.; Zhang, Q.; et al. Hesperetin
as an adjuvant augments protective anti-tumour immunity responses in B16F10 melanoma by stimulating
cytotoxic CD8 +T cells. Scand. J. Immunol. 2020,91, e12867. [CrossRef]
98.
Haggag, Y.A.; El-Ashmawy, N.E.; Okasha, K.M. Is hesperidin essential for prophylaxis and treatment of
COVID-19 Infection? Med. Hypotheses 2020,144, 109957. [CrossRef]
99.
Buscemi, S.; Rosafio, G.; Arcoleo, G.; Mattina, A.; Canino, B.; Montana, M.; Verga, S.; Rini, G. Effects of
red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased
cardiovascular risk. Am. J. Clin. Nutr. 2012,95, 1089–1095. [CrossRef]
100.
Knekt, P.; Kumpulainen, J.; Järvinen, R.; Rissanen, H.; Heliövaara, M.; Reunanen, A.; Hakulinen, T.; Aromaa, A.
Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002,76, 560–568. [CrossRef]
101.
Kim, J.; Wie, M.-B.; Ahn, M.J.; Tanaka, A.; Matsuda, H.; Shin, T. Benefits of hesperidin in central nervous
system disorders: A review. Anat. Cell Biol. 2019,52, 369–377. [CrossRef] [PubMed]
102.
Heo, S.D.; Kim, J.; Choi, Y.; Ekanayake, P.; Ahn, M.; Shin, T. Hesperidin improves motor disability in rat spinal
cord injury through anti-inflammatory and antioxidant mechanism via Nrf-2/HO-1 pathway. Neurosci. Lett.
2020,715, 134619. [CrossRef] [PubMed]
103.
Atabaki, R.; Roohbakhsh, A.; Moghimi, A.; Mehri, S. Protective effects of maternal administration of curcumin
and hesperidin in the rat offspring following repeated febrile seizure: Role of inflammation and TLR4.
Int. Immunopharmacol. 2020,86, 106720. [CrossRef] [PubMed]

Antioxidants 2020,9, 742 17 of 18
104.
Chanet, A.; Milenkovic, D.; Claude, S.; Maier, J.A.M.; Khan, M.K.; Rakotomanomana, N.; Shinkaruk, S.;
B
é
rard, A.M.; Bennetau-Pelissero, C.; Mazur, A.; et al. Flavanone metabolites decrease monocyte adhesion to
TNF-
α
-activated endothelial cells by modulating expression of atherosclerosis-related genes. Br. J. Nutr.
2013,110, 587–598. [CrossRef]
105.
Morand, C.; DuBray, C.; Milenkovic, D.; Lioger, D.; Martin, J.F.; Scalbert, A.; Mazur, A. Hesperidin contributes
to the vascular protective effects of orange juice: A randomized crossover study in healthy volunteers. Am. J.
Clin. Nutr. 2010,93, 73–80. [CrossRef]
106.
Al-Rikabi, R.; Al-Shmgani, H.; Dewir, Y.H.; El-Hendawy, S. In Vivo and In Vitro Evaluation of the Protective
Effects of Hesperidin in Lipopolysaccharide-Induced Inflammation and Cytotoxicity of Cell. Molecules
2020
,
25, 478. [CrossRef]
107.
Muhammad, T.; Ikram, M.; Ullah, R.; Rehman, S.U.; Kim, M.O. Hesperetin, a citrus flavonoid, attenuates
LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-kappaB
signaling. Nutrients 2019,11, 648. [CrossRef]
108.
Ghanim, H.; Sia, C.L.; Upadhyay, M.; Upadhyay, M.; Korzeniewski, K.; Viswanathan, P.; Abuaysheh, S.;
Mohanty, P.; Dandona, P. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate
meal and prevents endotoxin increase and Toll-like receptor expression. Am. J. Clin. Nutr.
2010
,91, 940–949.
[CrossRef]
109.
Johnston, C.S.; Dancho, C.L.; Strong, G.M. Orange juice ingestion and supplemental vitamin C are equally
effective at reducing plasma lipid peroxidation in healthy adult women. J. Am. Coll. Nutr.
2003
,22, 519–523.
[CrossRef]
110.
Bertoia, M.L.; Mukamal, K.J.; Cahill, L.E.; Hou, T.; Ludwig, D.S.; Mozaffarian, D.; Willett, W.C.; Hu, F.B.;
Rimm, E.B. Changes in Intake of Fruits and Vegetables and Weight Change in United States Men and Women
Followed for Up to 24 Years: Analysis from Three Prospective Cohort Studies. PLoS Med.
2015
,12, e1001878.
[CrossRef]
111.
Cassidy, A.; Bertoia, M.; Chiuve, S.; Flint, A.; Forman, J.; Rimm, E.B. Habitual intake of anthocyanins and
flavanones and risk of cardiovascular disease in men. Am. J. Clin. Nutr.
2016
,104, 587–594. [CrossRef]
[PubMed]
112.
Miller, V.; Mente, A.; Dehghan, M.; Rangarajan, S.; Zhang, X.; Bangdiwala, S.I.; Schutte, A.E.; Avezum, A.;
Altuntas, Y.; Ismail, N.; et al. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in
18 countries (PURE): A prospective cohort study. Lancet 2017,390, 2037–2049. [CrossRef]
113.
Schlesinger, S.; Neuenschwander, M.; Schwedhelm, C.; Hoffmann, G.; Bechthold, A.; Boeing, H.;
Schwingshackl, L. Food Groups and Risk of Overweight, Obesity, and Weight Gain: A Systematic Review and
Dose-Response Meta-Analysis of Prospective Studies. Adv. Nutr. 2019,10, 205–218. [CrossRef] [PubMed]
114.
Schwedhelm, C.; Schwingshackl, L.; Agogo, G.O.; Sonestedt, E.; Boeing, H.; Knüppel, S. Associations of food
groups and cardiometabolic and inflammatory biomarkers: Does the meal matter? Br. J. Nutr.
2019
,122,
1–10. [CrossRef] [PubMed]
115.
Polansky, H.; Lori, G. Coronavirus disease 2019 (COVID-19): First indication of efficacy of
Gene-Eden-VIR/Novirin in SARS-CoV-2 infection. Int. J. Antimicrob. Agents
2020
,55, 105971. [CrossRef]
[PubMed]
116.
Aune, D.; Giovannucci, E.; Boffetta, P.; Fadnes, L.T.; Keum, N.; Norat, T.; Greenwood, D.C.; Riboli, E.;
Vatten, L.J.; Tonstad, S. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer
and all-cause mortality—A systematic review and dose-response meta-analysis of prospective studies.
Int. J. Epidemiol. 2017,46, 1029–1056. [CrossRef]
117.
Collin, L.J.; Judd, S.; Safford, M.; Vaccarino, V.; Welsh, J.A. Association of Sugary Beverage Consumption with
Mortality Risk in US Adults: A Secondary Analysis of Data From the REGARDS Study. JAMA Netw. Open
2019,2, e193121. [CrossRef]
118.
Levine, M.; Conry-Cantilena, C.; Wang, Y.; Welch, R.W.; Washko, P.W.; Dhariwal, K.R.; Park, J.B.; Lazarev, A.;
Graumlich, J.F.; King, J.; et al. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended
dietary allowance. Proc. Natl. Acad. Sci. USA 1996,93, 3704–3709. [CrossRef]
119. Carr, A.C.; Maggini, S. Vitamin C and Immune Function. Nutrients 2017,9, 1211. [CrossRef]

Antioxidants 2020,9, 742 18 of 18
120.
Aune, D.; Keum, N.; Giovannucci, E.; Fadnes, L.T.; Boffetta, P.; Greenwood, D.C.; Tonstad, S.; Vatten, L.J.;
Riboli, E.; Norat, T. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and
cause specific mortality: Systematic review and dose-response meta-analysis of prospective studies. BMJ
2016,353, i2716. [CrossRef]
121.
Zanini, S.; Marzotto, M.; Giovinazzo, F.; Bassi, C.; Bellavite, P. Effects of Dietary Components on Cancer of
the Digestive System. Crit. Rev. Food Sci. Nutr. 2014,55, 1870–1885. [CrossRef] [PubMed]
122.
Herrera, D.; Serrano, J.; Rold
á
n, S.; Sanz, M. Is the oral cavity relevant in SARS-CoV-2 pandemic?
Clin. Oral Investig. 2020,24, 2925–2930. [CrossRef]
123.
Lamers, M.M.; Beumer, J.; Van Der Vaart, J.; Knoops, K.; Puschhof, J.; Breugem, T.I.; Ravelli, R.B.G.;
Van Schayck, J.P.; Mykytyn, A.Z.; Duimel, H.Q.; et al. SARS-CoV-2 productively infects human gut
enterocytes. Science 2020,369, 50–54. [CrossRef] [PubMed]
124.
Mattioli, A.V.; Sciomer, S.; Cocchi, C.; Maffei, S.; Gallina, S. Quarantine during COVID-19 outbreak: Changes
in diet and physical activity increase the risk of cardiovascular disease. Nutr. Metab. Cardiovasc. Dis.
2020
.
[CrossRef] [PubMed]
©
2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).